Incidence and risk factors for cervical lesions in patients with rheumatoid arthritis under the current pharmacologic treatment paradigm.

Objective: To elucidate the incidence and risk factors for cervical lesions in patients with rheumatic arthritis (RA) under the current pharmacologic treatment paradigm.

Methods: Of patients with RA onset after 2000, 151 who introduced biologic agents (BAs) because of high disease activity and underwent cervical radiography more than 5 years after onset were included. Incidence of those with cervical lesions and predictors of cervical lesions were analyzed.

Predictors for the progression of cervical lesion in rheumatoid arthritis under the treatment of biological agents.

Study Design: Retrospective cohort analysis.

Objective: To clarify the effect of biological agents (BAs) on the development and progression of cervical lesions in patients with rheumatoid arthritis (RA) and to identify biomarkers that accurately predict disease progression.

Summary Of Background Data: The introduction of BAs changed the paradigm of RA treatment.

Effect of biological agents on cervical spine lesions in rheumatoid arthritis.

Study Design: A retrospective cohort analysis.

Objective: To determine the effect of biological agents (BAs) on the development and progression of cervical spine lesions and identify predictors of lesion progression.

Summary Of Background Data: The introduction of BAs has facilitated advances in the treatment of rheumatoid arthritis (RA).